Schrier RW - Search Results

1

Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.

Schrier RW, Estacio RO, Mehler PS, Hiatt WR. Schrier RW, et al. Nat Clin Pract Nephrol. 2007 Aug;3(8):428-38. doi: 10.1038/ncpneph0559. Nat Clin Pract Nephrol. 2007. PMID: 17653121 Review.

2

Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis.

Schrier RW, Gurevich AK, Cadnapaphornchai MA. Schrier RW, et al. Semin Nephrol. 2001 Mar;21(2):157-72. doi: 10.1053/snep.2001.20933. Semin Nephrol. 2001. PMID: 11245778 Review.

3

Antihypertensive treatment in type II diabetes.

Schrier RW. Schrier RW. Hosp Pract (1995). 1998 May 15;33(5):13, 16. doi: 10.1080/21548331.1998.11443685. Hosp Pract (1995). 1998. PMID: 9606349 No abstract available.

4

Hemodynamic factors in the pathogenesis of diabetic nephropathy.

Schrier RW, Holzgreve H. Schrier RW, et al. Klin Wochenschr. 1988 Apr 15;66(8):325-31. doi: 10.1007/BF01735788. Klin Wochenschr. 1988. PMID: 3292819 Review.

5

Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.

Ecder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RW. Ecder T, et al. Among authors: schrier rw. Am J Kidney Dis. 2000 Mar;35(3):427-32. doi: 10.1016/s0272-6386(00)70195-8. Am J Kidney Dis. 2000. PMID: 10692268 Clinical Trial.

6

The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.

Savage S, Johnson Nagel N, Estacio RO, Feig PU, MacCarthy EP, Lukken NJ, Ziegler R, Schrier RW. Savage S, et al. Among authors: schrier rw. Online J Curr Clin Trials. 1993 Nov 24;Doc No 104:[6250 words; 128 paragraphs]. Online J Curr Clin Trials. 1993. PMID: 8305994 Clinical Trial.

7

Hypertension in autosomal dominant polycystic kidney disease.

Bell PE, Hossack KF, Gabow PA, Durr JA, Johnson AM, Schrier RW. Bell PE, et al. Among authors: schrier rw. Kidney Int. 1988 Nov;34(5):683-90. doi: 10.1038/ki.1988.233. Kidney Int. 1988. PMID: 2974094

8

Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.

Chapman AB, Schrier RW. Chapman AB, et al. Among authors: schrier rw. Semin Nephrol. 1991 Nov;11(6):653-60. Semin Nephrol. 1991. PMID: 1767138 Review.

9

Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.

Hensen J, Abraham WT, Dürr JA, Schrier RW. Hensen J, et al. Among authors: schrier rw. Am J Nephrol. 1991;11(6):441-6. doi: 10.1159/000168356. Am J Nephrol. 1991. PMID: 1840232

10

Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.

Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW. Ecder T, et al. Among authors: schrier rw. Nephrol Dial Transplant. 1999 May;14(5):1113-6. doi: 10.1093/ndt/14.5.1113. Nephrol Dial Transplant. 1999. PMID: 10344347 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results